AVDL

Avadel Pharmaceuticals

112 hedge funds and large institutions have $806M invested in Avadel Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 8 closing their positions.

Holders
112
Holders Change
+13
Holders Change %
+13.13%
% of All Funds
1.64%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
21
Increased
34
Reduced
27
Closed
8
Calls
$15.6M
Puts
$4.96M
Net Calls
+$10.6M
Net Calls Change
+$3.01M
Name Market Value Shares Shares
Change
Shares
Change %
HFS
101
Hantz Financial Services
Michigan
$11K 785
BWP
102
Baldwin Wealth Partners
Massachusetts
$7.06K 500
SIC
103
Salem Investment Counselors
North Carolina
$6.35K 450
GI
104
GAMMA Investing
California
$4.5K 313 +313 New
Daiwa Securities Group
105
Daiwa Securities Group
Japan
$3K 245
HIA
106
Harbor Investment Advisory
Maryland
$2.82K 200
AWM
107
Able Wealth Management
New Jersey
$1.62K 115 +115 New
LC
108
Lindbrook Capital
California
$1.38K 98
PA
109
Parallel Advisors
California
$593 42
S
110
SignatureFD
Georgia
$311 22 +22 New
HNB
111
Huntington National Bank
Ohio
$14 1
JGC
112
J. Goldman & Co
New York
-163,382 Closed
SCM
113
Soleus Capital Management
Connecticut
-104,000 Closed
SAM
114
Silverback Asset Management
North Carolina
-100,000 Closed
Qube Research & Technologies (QRT)
115
Qube Research & Technologies (QRT)
United Kingdom
-53,523 Closed
VF
116
Virtu Financial
New York
-20,047 Closed
Squarepoint
117
Squarepoint
New York
-14,582 Closed
Corient Private Wealth
118
Corient Private Wealth
Florida
-12,091 Closed
QT
119
Quantbot Technologies
New York
-7,587 Closed
Barclays
120
Barclays
United Kingdom
$0 24 -24 -50%
CFGS
121
Concourse Financial Group Securities
Alabama
Walleye Capital
122
Walleye Capital
New York
FIM
123
FWL Investment Management
Texas